Apex Drugs Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 35 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 135.21 Cr
- Revenue Growth %
- Net Worth 101.50%
- Total Assets -91.30%
About Apex Drugs
Apex Drugs Limited (ADL) is a Public Limited Indian Non-Government Company incorporated in India on 05 December 1989 and has a history of 35 years and four months. Its registered office is in Medak, Telangana, India.
The Corporate was formerly known as Apex Drugs And Intermediates Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company has closed loans amounting to ₹135.21 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Apex Drugs Limited India is Shankar Dige as CFO. Shankar Dige, Kajal Damania, and Gajanana Kudva serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230TG1989PLC010737
- Company No.
010737
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Dec 1989
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Apex Drugs Limited
Explore comprehensive data for Apex Drugs Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Apex Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shankar Dige  | Managing Director | 15-Sep-2021 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gajanana Kudva | Director | 29-Aug-2020 | Current |
| Kajal Damania | Director | 28-Aug-2020 | Current |
Financial Performance of Apex Drugs.
Apex Drugs Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 101.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Apex Drugs?
In 2022, Apex Drugs had a promoter holding of 99.94% and a public holding of 0.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Noma Infrastructure Private LimitedKajal Damania is a mutual person
Mvk Lifesciences Private LimitedKajal Damania and Gajanana Kudva are mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹135.21 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 70.53 Cr
- Bank Of India : 23.85 Cr
- Icici Bank Limited : 22.20 Cr
- Allahabad Bank : 16.00 Cr
- Oriental Bank Of Commerce : 1.56 Cr
- Others : 1.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2010 | Allahabad Bank | ₹16.00 Cr | Satisfied |
| 12 Sep 2008 | Bank Of India | ₹23.85 Cr | Satisfied |
| 23 Apr 2007 | Icici Bank Limited | ₹22.20 Cr | Satisfied |
| 24 Feb 2003 | State Bank Of India | ₹3.50 Cr | Satisfied |
| 24 Feb 2003 | State Bank Of India | ₹66.54 Cr | Satisfied |
How Many Employees Work at Apex Drugs?
Unlock and access historical data on people associated with Apex Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Apex Drugs
Recent activity within the organization
- Annual General Meeting
Apex Drugs Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
- Balance Sheet
Apex Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
- Charges
A charge registered on 01 Dec 2010 via Charge ID 10254676 with Allahabad Bank was fully satisfied on 15 Sep 2021.
- Charges
A charge registered on 12 Sep 2008 via Charge ID 10124609 with Bank Of India was fully satisfied on 15 Sep 2021.
- Director Appointment
Shankar Sitaram Dige was appointed as a Managing Director was appointed as a Managing Director on 15 Sep 2021 & has been associated with this company since 3 years 7 months .
- Director Appointment
Shankar Sitaram Dige was appointed as a Cfo was appointed as a Cfo on 15 Sep 2021 & has been associated with this company since 3 years 7 months .
Frequently asked questions
What is the Incorporation or founding date of Apex Drugs Limited?
Apex Drugs Limited was incorporated on 05 Dec 1989.
What is authorized share capital and paid-up capital of Apex Drugs Limited?
The authorized share capital of Apex Drugs Limited is ₹ 25.00 Cr and paid-up capital is ₹ 2.00 Cr.
Who are the current board members & directors of Apex Drugs Limited?
Currently 4 directors are associated with Apex Drugs Limited.
- Shankar Sitaram Dige
- Kajal Kiran Damania
- Gajanana Kudva
- Shankar Sitaram Dige
What is the registered address of Apex Drugs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Apex Drugs Limited is Survey No.14 Gaddapotharam India, Jinnaram, Telangana, 502319.
What is the corporate identification number (CIN) and company number of Apex Drugs Limited?
The corporate identification number (CIN) of Apex Drugs Limited is U24230TG1989PLC010737 and the company number is 010737 as per Ministry of Corporate Affairs (MCA).
What is the official website of Apex Drugs Limited?
The Official website of Apex Drugs Limited is https://www.apexdrugs.com
What change has been observed in the net worth of Apex Drugs Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Apex Drugs Limited has experienced an upsurge of 101.50%.
When was the last Balance Sheet of Apex Drugs Limited filed with the ROC?
The most recent Balance Sheet for Apex Drugs Limited was filed with the ROC on 31 Mar 2022.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Balaji VangipuramWholetime Director
Michael NigrelAdditional DirectorGK
Ghanshyam KurmiManaging DirectorVL
Vilas LokhandeWholetime DirectorSN
Satyanarayana NelakuditiDirectorSN
Sudhindra NayakDirectorRG
Ravi GangapalliWholetime DirectorSM
Subbaraju MudunuriAdditional Director
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India